Search research articles
Contact Us
Filters
Showing results (131-140 of 182) with videos related to
Page
of 19
Sort By:
HIV Medicine
|
January 12, 2024
Clinical epidemiology of COVID-19 in people of black ethnicity living with HIV in the UK
Zoe Ottaway, Lucy Campbell, Laura R Cechin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 15, 2018
Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial
Alejandro Arenas-Pinto, Birgit Grund, Shweta Sharma, et al.
Plos One
|
October 9, 2023
Preferences for oral PrEP dosing among adolescent boys and young men in three sub-Saharan African countries
Ayoub Kakande, Andrew Sentoogo Ssemata, Richard Muhumuza, et al.
Frontiers in Immunology
|
June 21, 2021
Epigenetic Features of HIV-Induced T-Cell Exhaustion Persist Despite Early Antiretroviral Therapy
Genevieve E Martin, Debattama R Sen, Matthew Pace, et al.
The Journal of Antimicrobial Chemotherapy
|
June 13, 2021
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV
Ana González-Cordón, Lambert Assoumou, Graeme Moyle, et al.
HIV Medicine
|
January 29, 2026
Screening for Trypanosoma cruzi infection (Chagas disease) in the Latin American population living with HIV in London
Natalie Elkheir, Shivani Singh, Birgit Barbini, et al.
The Journal of Antimicrobial Chemotherapy
|
August 4, 2023
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir
Ana González-Cordón, Lambert Assoumou, Graeme Moyle, et al.
Cell Reports
|
April 27, 2022
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants
Jeffrey Seow, Carl Graham, Sadie R Hallett, et al.
BMC Infectious Diseases
|
May 16, 2022
Symptoms of post-traumatic stress and associations with sexual behaviour and PrEP preferences among young people in South Africa, Uganda and Zimbabwe
Emily L Webb, Janan J Dietrich, Andrew S Ssemata, et al.
Frontiers in Immunology
|
September 16, 2022
Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption
Matthew Pace, Ane Ogbe, Jacob Hurst, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 182) with videos related to
Sort By:
Page
of 19
HIV Medicine
|
January 12, 2024
Clinical epidemiology of COVID-19 in people of black ethnicity living with HIV in the UK
Zoe Ottaway, Lucy Campbell, Laura R Cechin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 15, 2018
Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial
Alejandro Arenas-Pinto, Birgit Grund, Shweta Sharma, et al.
Plos One
|
October 9, 2023
Preferences for oral PrEP dosing among adolescent boys and young men in three sub-Saharan African countries
Ayoub Kakande, Andrew Sentoogo Ssemata, Richard Muhumuza, et al.
Frontiers in Immunology
|
June 21, 2021
Epigenetic Features of HIV-Induced T-Cell Exhaustion Persist Despite Early Antiretroviral Therapy
Genevieve E Martin, Debattama R Sen, Matthew Pace, et al.
The Journal of Antimicrobial Chemotherapy
|
June 13, 2021
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV
Ana González-Cordón, Lambert Assoumou, Graeme Moyle, et al.
HIV Medicine
|
January 29, 2026
Screening for Trypanosoma cruzi infection (Chagas disease) in the Latin American population living with HIV in London
Natalie Elkheir, Shivani Singh, Birgit Barbini, et al.
The Journal of Antimicrobial Chemotherapy
|
August 4, 2023
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir
Ana González-Cordón, Lambert Assoumou, Graeme Moyle, et al.
Cell Reports
|
April 27, 2022
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants
Jeffrey Seow, Carl Graham, Sadie R Hallett, et al.
BMC Infectious Diseases
|
May 16, 2022
Symptoms of post-traumatic stress and associations with sexual behaviour and PrEP preferences among young people in South Africa, Uganda and Zimbabwe
Emily L Webb, Janan J Dietrich, Andrew S Ssemata, et al.
Frontiers in Immunology
|
September 16, 2022
Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption
Matthew Pace, Ane Ogbe, Jacob Hurst, et al.
Page
of 19